Pembro Before and After Melanoma Surgery Boosts Outcomes
Patients with advanced melanoma have better event-free survival if pembrolizumab is given both before and after surgery; the findings tally with the mechanism of action of the drug, say researchers.
Medscape Medical News
source https://www.medscape.com/viewarticle/988932?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/988932?src=rss
Comments
Post a Comment